Department of Child and Adolescent Psychiatry, University of Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany.
Eur Child Adolesc Psychiatry. 2011 Oct;20 Suppl 2(Suppl 2):S267-75. doi: 10.1007/s00787-011-0204-2.
Although ADHD significantly affects the quality of life (QoL) of patients and their families, QoL in children with ADHD has rarely been investigated in association with psychopathological profile, and the relationship remains unclear. The open-label OBSEER study evaluated the effectiveness and tolerability of Equasym XL(®), a modified-release methylphenidate, in routine care of children and adolescents (aged 6-17 years) with ADHD. At baseline, questionnaires assessing psychopathological profile (Strengths and Difficulties Questionnaire, SDQ; parental ratings) and QoL (KINDL; parent, child or adolescent versions) were completed; QoL was reassessed at final visit. We analysed the relationship between psychopathology and parent/patient-rated QoL in ADHD at baseline. Data from 721 consecutively referred children and adolescents were analysed. QoL was similarly low from parent and self-ratings and independent of severity on the SDQ subscale hyperactivity/inattention. Self-ratings indicated that additional conduct disorder was associated with further reduction in QoL. Similarly, children with high scores from parent and adolescent ratings on the SDQ subscale conduct problems had reduced QoL on some KINDL subscales. Adolescents with ADHD not receiving medication at baseline reported lower QoL than those already on medication. Results show that children and adolescents with ADHD have low QoL, independent of core symptom severity. Additional conduct problems may further impact QoL negatively, while ADHD medication use may show a trend towards improved QoL. Not all psychopathological problems associated with ADHD affect QoL similarly. As parents appear to have a less critical view of QoL compared with children's self-ratings, both parent and child ratings should be included in clinical assessments.
尽管 ADHD 显著影响患者及其家属的生活质量(QoL),但 ADHD 儿童的 QoL 与精神病理学特征的关联研究较少,其关系尚不清楚。开放性 OBSEER 研究评估了 Equasym XL(®)(一种缓释哌甲酯)在 ADHD 儿童和青少年(6-17 岁)常规治疗中的疗效和耐受性。在基线时,使用调查问卷评估精神病理学特征(长处和困难问卷,SDQ;父母评分)和 QoL(KINDL;父母、儿童或青少年版本);在最后一次就诊时重新评估 QoL。我们分析了 ADHD 患者在基线时精神病理学与父母/患者报告的 QoL 之间的关系。对 721 例连续就诊的儿童和青少年进行了数据分析。来自父母和自我评分的 QoL 同样较低,与 SDQ 多动/注意力不集中亚量表的严重程度无关。自我评分表明,伴有品行障碍的 ADHD 患儿与 QoL 进一步降低有关。同样,SDQ 品行问题亚量表中父母和青少年评分较高的 ADHD 患儿在一些 KINDL 亚量表上的 QoL 降低。基线时未接受药物治疗的 ADHD 青少年报告的 QoL 低于已接受药物治疗的青少年。结果表明,ADHD 儿童和青少年的 QoL 较低,与核心症状严重程度无关。额外的品行问题可能会进一步对 QoL 产生负面影响,而 ADHD 药物治疗可能显示出改善 QoL 的趋势。并非所有与 ADHD 相关的精神病理学问题对 QoL 的影响都相同。由于父母对 QoL 的看法似乎不如儿童的自我评分那么苛刻,因此在临床评估中应同时包括父母和儿童的评分。